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INTRODUCTION
World Health Organisation stated in 2005 that 
“prisons act as a reservoir for TB, pumping the 
disease into the civilian community through staff, 
visitors and inadequately treated released inmates” 
(1). Correctional population have a much higher 
TB case rates than the general population due to 
overcrowding, poor ventilation, high prisoner 
turnover through repeated transfer, late case detection 
and inadequate treatment of infectious cases, co-
existing pathology, particularly HIV and intravenous 
drug use, poor nutritional status, physical/emotional 
stresses (2) and the fact that a disproportionate number 
of prisoners are derived from population groups 
already at high risk of TB infection and disease (3) (e.g. 
those addicted to alcohol or illicit drugs, the homeless, 
the mentally ill, former prisoners), who often do not 
have access to adequate treatment in civilian life (2).
This combination of factors makes implementation 
of TB-control measures in correctional and detention 
facilities particularly difficult (4). 
 In 2005, Kenya was ranked tenth out of the twenty 
two high TB burdened countries in the world, based on 
estimated number of all forms of incident TB case (5). 
The total number of TB cases reported in 2005 was nine-
fold compared to that reported in 1990. HIV epidemic, 
poor socioeconomic status, over crowded slums in 
the peri-urban areas coupled with poor nutrition and 
limited access to health services have been identified as 
contributing factors to the increasing TB burden (6). It 
is thus fundamental to establish the factors associated 
with high TB rates in our prisons in order to implement 
effective and cost-effective control programmes. Effective 
MTB infection control in prisons protects the well-being 
of both the prisoners and the wider community (2). Very 
few studies have been done in Africa to investigate the 
risk factors for TB (7), with those associated with active 
PTB disease among prisoners in Kenya not clearly 
defined. We carried out this study with the objective 
of establishing the modifiable factors associated with 
active PTB disease among prisoners at the Nakuru GK 
prison, in Kenya; in order to make recommendations for 
improved TB control. 
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ABSTRACT
Objectives: To establish modifiable factors associated with active pulmonary tuberculosis 
(PTB) among prisoners. 
Design: Retrospective matched case-control study.
Setting: Nakuru GK prison in Kenya. 
Subjects: A total of l44 subjects (48 cases and 96 controls) were recruited into the study. 
Cases were adult prisoners who had at least two initial sputum specimens being Acid 
Fast Bacilli-positive (AFB+) on direct smear microscopy and hence recruited to PTB 
WHO DOTS Programme. Controls were adults with no chronic cough and not on PTB 
treatment six months prior to the study.  
Results: Independent factors significantly associated with active PTB disease were: 
self reported HIV+ status (OR=11; 95%CI = 2.42-47.77), evidence of BCG vaccination 
(OR = 0.20; 95%CI = 0.05-0.60), contact with PTB case (OR = 7.0; 95%CI =1.17-38.23), 
unemployment (OR = 9.0; 95%CI = 1.84-43.97) and sharing linen (OR = 4.32; 95%CI 
= 1.08-17.29). 
Conclusions: Modifiable factors associated with active PTB in Nakuru G.K prison are: 
HIV status, BCG vaccination, PTB case contact, poverty and poor personal hygiene. 
We recommend HIV counselling and testing of all PTB patients, screening for TB 
upon prison entry and TB contact investigation and improving personal hygiene of 
prisoners. 
44 EAST AFRICAN MEDICAL JOURNAL February 2010 
MATERIALS AND METHODS
Study site: The Nakuru G.K prison is one of the 93 
penal institutions in Kenya. It is located about 5 km 
from the central business area of Nakuru town and 
was constructed to hold 800 prisoners. The male and 
female wing is separated and served by different 
health clinics. During the three and a half month 
study period it had a daily mean of 1,716 male and 
172 female prisoners respectively. 
Study design: A retrospective case control study 
matched by age and sex was conducted at the 
Nakuru G.K prison between 28th August and 12th 
December 2007. 
Case and control definition: A case was defined as 
“any adult prisoner (pre-trial or sentenced prisoner 
aged > 16 years) who had at least two initial sputum 
specimens being Acid Fast Bacilli-positive (AFB+) 
on direct smear microscopy and hence recruited 
to PTB WHO DOTS Programme”. Controls were 
prisoners with no chronic cough and not on PTB 
treatment six months prior to the study. Prisoner who 
self-reported being diagnosed of active PTB disease 
before incarceration i.e. community acquired PTB 
were excluded from the study. 
Enrollment and sampling procedures: The cases were 
enrolled by review of the TB register at the prison 
health clinic then physically identified and a face-
to-face interview conducted using a questionnaire. 
From the daily register of prisoners, a simple random 
sampling method (without replacement) was used 
to select participants meeting the control definition. 
Each enrolled PTB case was allocated two controls 
matched by sex and five-year age interval. The case 
together with its two matched controls, were assigned 
a similar unique identifying number which was then 
used during analyses. 
Sample size determination: A minimum sample size of 
138 was determined using the Fleiss formula (8), based 
on the assumptions that the proportion of active PTB 
patients and controls exposed to host/environmental 
factors under study was 56% and 30% respectively, 
with the case to control ratio at 1:2, power at 80% and 
95% confidence interval. 
Data collection tools and methods: A pre-tested semi-
structured questionnaire was administered to all 
enrolled study subjects, to collect data on possible 
host/environmental factors associated with active 
PTB disease. Study subjects were checked for a typical 
Bacille Calmette - Guerin (BCG) scar on the upper 
outer part of the left forearm. Weight (in kilograms) 
and height (in metres) measurements were taken at 
the time of enrollment. They were used to compute 
Body Mass Index (BMI) by dividing weight with 
height squared (weight/height2). The BMI cutoff 
points considered were underweight (below 18.5); 
normal weight (18.5 to 24.9); overweight (25 to 29.9); 
obese (above 30) (9). 
Data management and analysis: Data were coded during 
collection. Epi Info version 3.4.3 statistical software 
was used for data entry and analysis. Descriptive 
analysis based on frequency distribution of the selected 
socio-demographic characteristics was done. Matched 
analysis was performed for the factors associated 
with active PTB disease, with measure of association 
being Adjusted (Mantel Hansel) Odds Ratio (OR). 
McNemars chi-square test was used for categorical 
variables at 95% confidences interval (CI) with alpha 
level of significance at 0.05. Conditional logistic 
regression was applied to calculate OR for the exposure 
variables that were statistically significant during 
matched analysis, while controlling simultaneously 
for multiple “potential” confounders. A stepwise 
backward elimination procedure was conducted 
to obtain a reduced model. To identify complex 
interaction, a pair of biologically sensible variables 
was entered in a conditional logistic model with the 
unique number used as the matching variable. An 
alpha level of  0.05 was used to determine the statistical 
significance of the interactions between pairs of 
biological sensible factors and active PTB disease. 
Ethical issues: Clearance for the study was sought 
and obtained from the Jomo Kenyatta University of 
Agriculture and Technology Board of Postgraduate 
Studies, Permanent Secretary, Ministry of Science 
and Technology and the Commissioner of Prison 
Service of Kenya, before commencement of the study. 
Informed written consent was sought and obtained 
from the study subjects before administration of 
questionnaire. 
RESULTS
One hundred and forty four inmates (48 cases and 
96 controls) were recruited for this study, with 135 
(94%) being male. Seventy six of the study subjects 
reported having attained primary school education 
while 93 (65%) reported having been self employed 
prior to incarceration. The ages of the study subjects 
ranged from 19 to 70 years (median age = 31 years). 
Eighty nine (62%) of the enrolled inmates had 
been incarcerated for a period of one year or less. 
Approximately 14 (10%) of the study subjects were 
found to be underweight while approximately 14% 
were found to be overweight. 
 Overall 96 (67%) of the study subjects admitted 
knowing their HIV status of which 36 (38%) were PTB 
cases while 60 (62%) were in the control group. The 
commonest symptoms reported by cases was night 
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sweats 36 (75%) followed by chest pains 32 (67%) 
(Figure 1). The median duration of anti-TB medication 
was 66 days (range 1- 150 days). 
 During matched analysis the significant factors 
associated with active PTB disease were: self reported 
HIV+ status (OR = 9.4,95% Cl = 3.2- 27.09), history of 
prison transfer (OR = 3.0, 95% C I= 1.32-5.40), history 
of a sexually transmitted infection (STI) (OR = 3.0, 
95% CI = 1.43-6.28), sharing towels and clothes with 
other inmates while in incarceration (OR = 2.5,95% CI 
= 1.22-5.13), contact with PTB case (OR = 9.0, 95% CI 
= 2.90-29.46), alcohol consumption history (OR = 4.5, 
95%CI = 1.98-10.21), smoking history (OR = 3.0, 95% CI 
= 1.42-5.59) and unemployment prior to incarceration 
(OR = 6.0, 95%CI = 2.31-5.60). The presence of BCG 
scar was the only significant protective factor (OR = 
0.2, 95% CI = 0.09-0.43) (Table 1). 
Table 1
Results of factors associated with active PTB infection at Nakuru GK prison during matched and multivariate 
analysis
Exposure   Matched analysis   Multivariate analysis 
 Case  Control  Adjusted     
 No. (%)  No. (%)  OR(MH)  95%CI  OR  95%CI  P-value 
Self reported HIV + status  27  56  12  13  9.40  3.2- 27.09  10.75  2.42-47.77  0.0018 
Presence of BCG scar  17  35  76  79  0.19  0.09-0.43  0.17  0.05-0.60  0.0059 
Unemployment  22  46  14  15  6.00  2.31-5.60  8.98  1.84-43.97  0.0067 
Contact with PTB case  42  88  51  53  9.25  2.90-29.46  6.68  1.17-38.23  0.0329 
Sharing linen
(clothes/towel)  21  44  21  22  2.50  1.22-5.13  4.32  1.08-17.29  0.0386 
Prison transfer†  29  60  33  34  2.60  1.32-5.40   **NS  
History of STI†  25  52  24  25  3.00  1.43-6.28   **NS  
Alcohol consumption†  34  71  33  34  4.50  1.98-10.21   **NS  
History of smoking†  28  58  27  28  2.81  1.42-5.59   **NS  
Lack of formal education*  9   19  10  10  2.00  0.74-5.37   **NS  
Low BMI <18.5*  4    8  7    7  1.14  0.33-3.92   **NS  
Having diabetes*  3    6  2    2  3.00  0.42-21.30   **NS  
Prison stay >3 months*  30  63  67  70  0.67  0.29-1.15   **NS  
Prison stay >6 months*  26  54  55  57  0.86  0.41-1.83   **NS  
Prison stay> 12 months *  17  35  38  55  0.83  0.40-1.73   **NS 
† Factors associated with active PTB infection during matched analysis (p<0.05) that dropped 
out from the multivariate analysis model. 
* Factors not statistically significant during matched analysis (p>0.05) and hence not entered 
into the multivariate analysis model 
**NS= Not Significant 
Figure 1
Distribution of the clinical presentation of active 























% of active pulmonary tuberculosis patients
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DISCUSSION
The findings from this study indicate that TB and 
HIV epidemics are closely intertwined in Nakuru 
GK prison settings. Self - reported HIV+ status was 
the strongest risk factor associated with active PTB 
disease though the HIV status could not be ascertained 
through review of medical records because they were 
poorly maintained and incomplete. These results are 
comparable to those documented elsewhere where 
the estimated risk of clinical disease in HIV-infected 
persons was between 6 to 26 times higher than in non-
HIV infected persons (10). The association between TB 
and sexual behaviour has rarely been studied, except 
in the context of HIV infection. Nevertheless in a study 
in the United States inmates who reported a history 
of TB also reported higher sexual risk factors than 
those without such a history, although confounding 
by HIV infection could not be entirely ruled out (11). 
Typically, any sexual behaviour is disallowed by 
prison rules. However it may take many forms, from 
the request for sex (consensual sex) to forced sodomy. 
For some inmates, sex is a survival strategy (12). Many 
prisoners usually come from populations lacking 
access to reproductive and sexual health services. 
Prevention, regular screening and treatment of STIs 
among prisoners would decrease risk of HIV/AIDS 
and by extension lead to reduction of TB incidence. 
 Bacille Calmette - Guerin (BCG) vaccination is a 
part of the WHO recommended routine immunisation 
programme for children in Kenya and hence the 
presence of a typical BCG vaccination scar on the 
outer upper part of the left forearm was taken as 
evidence of previous BCG vaccination (4). This 
study demonstrated that presence of BCG scar was 
protectively associated with active PTB among adults 
imprisoned at Nakuru GK prison contrary to other 
studies carried out in Africa (13). The role of BCG 
vaccine booster dose in adults, need to be further 
investigated. 
 In this study, lack of formal education and/or 
unemployment prior to incarceration, were taken 
as proxies for low social economic status (SES). Our 
statistical significant finding on unemployment 
concurs with a study in Russia(14) and reiterates that 
TB is a disease of the poor and prisoners at Nakuru 
GK prison are deprive from society of low SES. 
 The model building procedure involved entering 
these nine variables with a p-value of <0.05 during 
the matched analysis in the conditional logistic 
regression model. The “Best Final Model” had five 
variables independently associated with active PTB. 
Self reported HIV+ status was found to be the strongest 
risk factor independently associated with active PTB 
disease while presence of BCG scar was the only 
independent protective factor. Other independent risk 
factors were; unemployment prior to incarceration, 
contact with PTB case during incarceration period and 
sharing towel/clothes with other inmates (Table 1). No 
statistically significant complex interaction terms were 
identified as modifying the association between pairs of 
exposure variables and active PTB disease (Table 2).
Table 2
Results for the complex interaction terms analysis on factors associated with active PTB infection at Nakuru GK 
prison in Kenya, 2007
Complex interaction term  Odds ratio  95%CI  P-value 
Alcohol consumption and    
smoking  0.37  0.07 - 1.90  0.232 
Contact with PTB case and    
sharing linen  1.26  0.15 - 10.75  0.834 
HIV+ status and STI  5.11  0.47 - 55.60  0.181 
Lack of formal education and    
unemployment  1.49  0.16 - 13.56  0.726 
Diabetes and low BMI  223452.81  0.00 >1.0E12  0.968 
HIV+ status and low BMI  0.19  0.01 - 6.17  0.348 
Duration of incarceration    
> 1 year and prison transfer  0.59  0.12 - 2.89  0.515 
Duration of incarceration    
>6 Months and prison transfer  0.53  0.12-2.39  0.408 
Duration of incarceration    
> 3 months and prison transfer  0.60  0.12-2.93  0.531 
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 Contact with a person suffering from PTB while 
under incarceration was independently associated 
with active PTB disease. This finding concurs with 
those from a clinic based study conducted in Gambia 
(15).This suggests lack of isolation of patients with 
active PTB disease leading to transmission of infection 
to other inmates either before diagnosis is made or 
during the early treatment period when one is still 
infectious. 
 The fact that sharing of linen was significantly 
associated with active PTB indicates the occurrence of 
personal unhygienic conditions in Nakuru GK prison. 
These findings show similarities to those observed at 
St. Petersburg remand prison in Russia (16). 
  Forty three per cent of the study subjects 
reported being transferred within and outside the 
Nakuru GK prison, a factor that was only significant 
during matched but not multivariate analysis. Studies 
conducted in Pakistan’s correctional facilities reported 
an association between history of prison transfer and 
latent PTB infection among prisoners (4). 
 The statistical significance of cigarette smoking 
found in this study is consistent with that reported in 
a community-based case-control study in West Africa 
(17). However, this exposure was not found to be an 
independent risk factor after controlling for multiple 
potential confounders, which had not been addressed 
in the above previous studies. An effective anti- 
smoking campaign boosted by the implementation 
of the recently enacted “Tobacco Control Act 2007 in 
Kenya, could have a positive outcome on reduction 
of TB incidence in Nakuru GK prison.
 Alcohol consumption was significantly 
associated with active PTB disease among prisoners 
during bivariate but not multivariate analysis. These 
results are contrary to those reported from India 
(18) which found alcohol consumption to be an 
independent predictor of active PTB disease. The 
alcohol consumption finding in our study could 
have been underestimated due to security reasons 
prohibiting strict privacy to this sensitive question.
 Lack of formal education, being diabetic and low 
BMI score were not significantly associated with active 
PTB disease in this study. Eliciting the correct response 
for level of education (being a sensitive question), 
during the study period was affected by response bias 
as it was not possible to conduct the questionnaire 
interviews in strict privacy due to security reasons. 
This could have affected any significant association 
expected from this variable in our study. The small 
sample size among the diabetic prisoners (4%) could 
have affected our results for this exposure. Lack of 
a significant association of the low BMI value could 
be related to supplementary diet offered to the PTB 
patients at Nakuru GK prison. 
 In this study, 45% of prisoners had been in 
prison for less than 200 days. This suggests that 
prison terms at the Nakuru GK prison are rather 
short. This could have led to underestimation of the 
true effect of this exposure factor to the active PTB 
cases observed. Incarceration duration of more than 
six months was found to be a risk factor for active TB 
among prisoners in Botswana, in a one-time survey 
in a prison system without regular screening at entry 
(19) and in Cameroon a prison stay of less than 12 
months, and a history of previous incarceration 
were positively associated with PTB (20). Our study 
focused on incident PTB cases after imprisonment. 
Prisoner who self-reported being diagnosed of active 
PTB disease before incarceration were excluded from 
this study in order to minimise the bias associated 
with community acquired PTB. The association 
between the length of incarceration and active PTB 
was not statistically significant during analysis done 
at bivariate level and at the complex interaction terms 
level (Tables 1 and 2). 
 This study being the first to investigate 
factors associated with active PTB disease within 
a prison population in the Kenya’s correctional 
system, will thus form a basis for other studies on 
factors associated with active PTB disease within 
other prisons in the Kenya’s correctional system. 
A comprehensive multidisciplinary control and 
preventive approach involving corroboration 
between prisoners, health officials and prison 
authorities, should be adopted in order to reduce 
the risk associated with PTB control at Nakuru GK 
prison. This should involve HIV counselling and 
testing of all PTB patients, screening for TB upon 
prison entry, TB contact investigation and improving 
person hygiene of prisoners. 
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